For more information about RRC, please contact our Client Service division.
If you require technical assistance with this website, please contact the RRC Webmaster.
Press Releases 29 January 2006 Novartis, Pfizer, GlaxoSmithKline Win Top Honors in First-Ever Study of Drug Company Reputation Strength in Europe 1 July 2005 Good News–Bad News on Pharma Ethics: New Ethics Study Reveals a “High Quality” Image 13 May 2005 Pharma CEOs Under Pressure: Big Changes in CEO Effectiveness Rankings for 2005 11 May 2005 Reputation Ratings of Five Big Pharma Firms Downgraded, Three Upgraded by Rating Research LLC 23 February 2005 American Drug Companies Out of Sync with Public Opinion on their Ethics, Opinion Researchers Report 9 June 2004 Electric Power Industry Study, 2002-2004: Tarnished Reputations, Shining Stars 5 November 2003 Industry Executives and Financial Analysts Rank Leadership Abilities of Pharmaceutical CEOs in Annual Rating Research Reputation Study 21 August 2003 Rating Research Confirms FirstEnergy’s Low Quality “B” Reputation Rating 9 July 2003 Eli Lilly Leads Industry on Charitable Issues in New Rating Research Study 25 June 2003 Rating Research’s ‘03 Pharmaceutical Reputation Study Surfaces Changing Focus of C-Suite Executives 6 June 2003 Rating Research Assigns AAA Reputation Ratings To Pfizer, Merck And J&J 4 June 2003 Rating Research Downgrades Bristol-Myers Squibb’s Reputation Rating 2 June 2003 Rating Research Upgrades Pfizer’s Reputation Rating 15 March 2003 Northern Trust Assigned Highest Ethics Reputation Rating by Rating Research 4 March 2003 Rating Research Assigns “AA” Reputation Ratings to Northern Trust, Fifth Third 30 January 2003 Reputation Information on Pharmaceutical Companies Most Sought by Investors According to Rating Research Survey 10 January 2003 Individual Investors’ Faith in Corporate America’s Ethics Remains Dismally Low According to Rating Research Survey 9 January 2003 Rating Research Investor Confidence Index Indicates Individual Investors Remain Unenthusiastic Heading into 2003 5 December2002 Investor Confidence in Financial Information Remains Low 6 September2002 Rating Research Survey Reveals Investor Skepticism in all Sources of Investment Information 23 July 2002 Rating Research Survey Reveals Duke Energy and Southern Company are Industry's Reputation Leaders 17 July 2002 Rating Research Survey Reveals Growing Mistrust by Investors in Investment Information 26 June 2002 J&J and Merck Receive Highest Ratings on Industry Reputation Survey 29 April 2002 Retail Reputation Study Reveals Opinion Gap Between Industry Executives and Analysts For information about the company as featured in other publications, please visit our RRC in the News section.
Press Releases
29 January 2006 Novartis, Pfizer, GlaxoSmithKline Win Top Honors in First-Ever Study of Drug Company Reputation Strength in Europe
1 July 2005 Good News–Bad News on Pharma Ethics: New Ethics Study Reveals a “High Quality” Image
13 May 2005 Pharma CEOs Under Pressure: Big Changes in CEO Effectiveness Rankings for 2005
11 May 2005 Reputation Ratings of Five Big Pharma Firms Downgraded, Three Upgraded by Rating Research LLC
23 February 2005 American Drug Companies Out of Sync with Public Opinion on their Ethics, Opinion Researchers Report
9 June 2004 Electric Power Industry Study, 2002-2004: Tarnished Reputations, Shining Stars
5 November 2003 Industry Executives and Financial Analysts Rank Leadership Abilities of Pharmaceutical CEOs in Annual Rating Research Reputation Study
21 August 2003 Rating Research Confirms FirstEnergy’s Low Quality “B” Reputation Rating
9 July 2003 Eli Lilly Leads Industry on Charitable Issues in New Rating Research Study
25 June 2003 Rating Research’s ‘03 Pharmaceutical Reputation Study Surfaces Changing Focus of C-Suite Executives
6 June 2003 Rating Research Assigns AAA Reputation Ratings To Pfizer, Merck And J&J
4 June 2003 Rating Research Downgrades Bristol-Myers Squibb’s Reputation Rating
2 June 2003 Rating Research Upgrades Pfizer’s Reputation Rating
15 March 2003 Northern Trust Assigned Highest Ethics Reputation Rating by Rating Research
4 March 2003 Rating Research Assigns “AA” Reputation Ratings to Northern Trust, Fifth Third
30 January 2003 Reputation Information on Pharmaceutical Companies Most Sought by Investors According to Rating Research Survey
10 January 2003 Individual Investors’ Faith in Corporate America’s Ethics Remains Dismally Low According to Rating Research Survey
9 January 2003 Rating Research Investor Confidence Index Indicates Individual Investors Remain Unenthusiastic Heading into 2003 5 December2002 Investor Confidence in Financial Information Remains Low
6 September2002 Rating Research Survey Reveals Investor Skepticism in all Sources of Investment Information
23 July 2002 Rating Research Survey Reveals Duke Energy and Southern Company are Industry's Reputation Leaders
17 July 2002 Rating Research Survey Reveals Growing Mistrust by Investors in Investment Information
26 June 2002 J&J and Merck Receive Highest Ratings on Industry Reputation Survey
29 April 2002 Retail Reputation Study Reveals Opinion Gap Between Industry Executives and Analysts
For information about the company as featured in other publications, please visit our RRC in the News section.
